Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 3, 2004, Pages 488-493

  Iwasaki, Akinori ^a   Shirakusa, Takayuki ^a   Yoshinaga, Yasuteru ^a   Enatsu, Sotarou ^a   Yamamoto, Masaaki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Metastatic brain tumor; NSCLC; Prognosis; Risk score

Indexed keywords

BRAIN METASTASIS; BRAIN SURGERY; CANCER SURVIVAL; EVALUATION; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; AGED; BRAIN; BRAIN NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 4143122174     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.05.049     Document Type: Review

References (22)

1. Hotta K., Sekine I., Suzuki K., Kondo H., Asamura H., Sumi M., Yamamoto N., Kunitoh H., Ohe Y., Tamura T., Kodama T., Saijo N., Tsuchiya R. Distant failure after treatment of postoperative locoregional recurrence of non-small cell lung cancer. Thorac Cardiovasc Surg. 51:2003;283-287
2. Mauntain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717
3. Figlin R.A., Piantadosi S., feld R., Lung Cancer Study Group. Intercranial recurrence of carcinoma after complete surgical resection of stage I,II, and III non-small-cell lung cancer. N Engl J Med. 318:1998;1300-1305
4. Takeshima H., Kuratsu J., Nishi T., Ushio Y. Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: report of 5 cases and review of the literature. Surg Neurol. 58:2002;118-123
5. Sheehan J.P., Sun M.H., Kondziolka D., Flickinger J., Lunsford L.D. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg. 97:2002;1276-1281
6. Markmann J.F., Gornbein J., Markowitz J.S., Levy M.F., Klintmalm G.B., Yersiz H., Morrisey M., Drazan K., Farmer D.G., Chobrial R., Goss J., Seiu P., Martin P., Goldstein L.I., Busuttil R.W. A simple model to estimate survival after retransplantation of the liver. Transplantation. 67:1999;422-430
7. Burt M., Wronski M., Arbit E., Galicich J.H., the Memorial Sloan-Kettering Cancer Treatment Thoracic Surgical Staff. Resection of brain metastases from non-small cell carcinoma: results of therapy. J Thorac Cardiovasc Surg. 103:1992;399-410
8. Oldberg E. Surgical considerations of carcinoma metastases to the brain. J Am Med Assoc. 101:1993;1458
9. Mussi A., Pistolei M., Lucchi M., Janni A., Chella A., Parenti G., Rossi G., Angeletti C.A. Resection of single brain metastasis in non-small cell lung cancer: progno[s]tic factor. J Cardiovasc Surg. 112:1996;146-153
10. Jacot W., Quantin X., Boher J.M., Andre F., Moreau L., Gainer M., Depierre A., Quoix E., Chevalier T.L., Pujol J.L. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer. 84:2001;903-909
11. Ohta Y., Oda M., Tsunezuka Y., Uchiyama N., Nishijima H., Takanaka T., Ohnishi H., Kohda Y., Yamashita J., Watanabe G. Results of recent therapy for non-small-cell lung cancer with brain metastasis as the initial relapse. Am J Clin Oncol. 25:2002;476-479
12. Amin M.B., Tamboli P., Merchant S.H., Ordonez N.G., Ro J., Ayala A.G., Ro J.Y. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 26:2002;358-364
13. Shabani H.K., Kitange G., Tsunoda K., Anda T., Tokunaga Y., Shibata S., Kaminogo M., Hayashi T., Ayabe H., Iseki M. Immunohistochemical expression of E-cadherin in metastatic brain tumors. Brain Tumor Pathol. 20:2003;7-12
14. Buccheri G., Ferrigno D. Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg. 75:2003;973-980
15. Sawabata N., Ohta M., Takeda S., Hirano H., Okumura Y., Asada H., Maeda H. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg. 74:2002;174-179
16. Bubb R.S., Komaki R., Hachiya T., Milas I., Ro J.Y., Langford L., Sawaya R., Putnam J.B., Allen P., Cox J.D., McDonnell T.J., Brock W., Hong W.K., Roth J.A., Milas L. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion. Int J Radiat Oncol Biol Phys. 53:2002;1216-1224
17. D'Amico T.A., Aloia T.A., Moore M.B., Conlon D.H., Herndon J.E. 2nd, Kinch M.S., Harpole D.H. Jr. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg. 72:2001;1144-1148
18. Ohshima K., Hamasaki M., Makimoto Y., Yoneda S., Fujii A., Takamatsu Y., Nakashima M., Watanabe T., Kawahara K., Kikuchi M., Shirakusa T. Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis. Int J Oncol. 23:2003;965-973
19. Iwasaki A., Kuwahara M., Yoshinaga Y., Shirakusa T. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiovasc Surg. 25:2004;443-448
20. Kusters B., de Waal R.M., Wesseling P., Verrijp K., Maass C., Heerschap A., Barentsz J.O., Sweep F., Ruiter D.J., Leenders W.P. Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. Cancer Res. 63:2003;5408-5413
21. Sawa T., Yoshida T., Ikoma T., Toyoda M., Ohno Y., Fujiwara H. Evaluation of the increasing serum lactate dehydrogenase caused by recombinant human granulocyte-colony stimulating factor. Gan To Kagaku Ryoho. 30:2003;51-58
22. Tas F., Aydiner A., Demir C., Topuz E. Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer. Am J Clin Oncol. 24:2001;376-378